Industry

BEIJING, China & TOKYO–(BUSINESS WIRE)–#CCR8–February 1st 2021, Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”) entered a strategic collaboration with LiberoThera Co., Ltd (“LiberoThera”) to co-develop fully human GPCR antibodies using Biocytogen’s advanced antibody discovery platform based on fully human antibody RenMabTM mice combined with LiberoThera’s outstanding membrane antigen preparation technology. In around a year since the … [Read more…]

LOS ANGELES–(BUSINESS WIRE)–#monkeypox–With the World Health Organization set to meet for the second time tomorrow to decide whether to declare monkeypox a Public Health Emergency of International Concern (PHEIC), AIDS Healthcare Foundation strongly urges the WHO to acknowledge the rapid, uncontrolled spread of the virus and declare it a pandemic. Monkeypox has spread to over … [Read more…]

OAKLAND, Calif.–(BUSINESS WIRE)–#CWCI–Proposals to cut the amount of time California workers’ compensation claims administrators have to investigate work-related injuries and determine employer liability may be easier said than done given existing statutory and regulatory time frames for the various steps within the process, many of which claims organizations do not control, according to a new … [Read more…]

BOULDER, Colo.–(BUSINESS WIRE)–$CLVS–First paragraph, second sentence of release should read: Clovis’ senior management will host a conference call and live audio webcast at 8:30am ET to discuss Clovis’ results and business outlook in greater detail. (instead of Clovis’ senior management will host a conference call and live audio webcast at 6:30am ET to discuss Clovis’ … [Read more…]

The Glioblastoma Foundation Launches Several Initiatives in Support of its National Commitment to Ensuring Accessible, Individualized Patient Care and Treatment DURHAM, N.C.–(BUSINESS WIRE)–Glioblastoma Awareness Day observed today, July 20, 2022, aims to increase public awareness of glioblastoma and honor those who have lost their lives to the devastating disease. In conjunction with the observance, the … [Read more…]

DALLAS & NEW YORK–(BUSINESS WIRE)–Signify Health, Inc. (NYSE: SGFY), a leading value-based healthcare platform enabled by advanced analytics, technology and nationwide healthcare networks, announced that it will release its financial results for the second quarter 2022 after the market closes on Wednesday, August 3, 2022, and will hold a conference call at 8:30am ET on … [Read more…]

EXETER, N.H.–(BUSINESS WIRE)–Vapotherm, Inc. (NYSE: VAPO) (“Vapotherm” or the “Company”), a global medical technology company focused on the development and commercialization of its proprietary Vapotherm high velocity therapy® products which are used to treat patients of all ages suffering from respiratory distress, today announced that it will release financial results for the second quarter of … [Read more…]

KGK to conduct Phase II clinical trial to test the efficacy of psilocybin on treatment resistant PTSD VANCOUVER, British Columbia–(BUSINESS WIRE)–$KONEF #ketamine–Wellbeing Digital Sciences Inc. (“Wellbeing” or the “Company”) (NEO: MEDI) (OTC: KONEF) (FRA: SQ2), an evidence-based mental healthcare company focused on the development and implementation of innovative clinical solutions, including psychedelic medicine and digital … [Read more…]

The Genomic Test Demonstrated 100 Percent Sensitivity and 100 Percent Specificity for MTC SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Veracyte, Inc. (Nasdaq: VCYT) today announced that new clinical validation data published online in Thyroid show that the company’s RNA sequencing-based Afirma Medullary Thyroid Cancer (MTC) Classifier demonstrated high sensitivity and specificity in identifying MTC among pre-operative thyroid … [Read more…]

CHICAGO–(BUSINESS WIRE)–Exicure, Inc. (Nasdaq: XCUR), an early-stage biotechnology company focused on the development of next generation nucleic acid therapies targeting RNA to address both genetic and non-genetic neurological disorders and hair loss disorders, today announced that on July 19, 2022, it received a letter from the Office of General Counsel of The Nasdaq Stock Market … [Read more…]